tm
Seeing Is Believing
tm
Seeing Is Believing
Aptevo Therapeutics's activity chart (see below) currently has 9 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 15.71% with an average time for these price targets to be met of 318.25 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2021
$1172160
2 years 1 months 18 days ago
(23-Sep-2024)
0/2 (0%)
$172160 (17.22%)
Buy Since 12-Mar-2019
$421977.56
$421976.34 (34030348.00%)
4 years 2 months 29 days ago
(12-Aug-2022)
1/5 (20%)
$-578022.44 (-57.80%)
355
Buy Since 05-Nov-2018
$2083840
$2083835.5 (45698144.00%)
6 years 2 days ago
(09-Nov-2020)
0/1 (0%)
$1083840 (108.38%)
What is APVO (Aptevo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on APVO (Aptevo Therapeutics)?
Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?
Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?
Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?
